Proficio Capital Partners LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 194,031 shares of the medical research company’s stock, valued at approximately $26,066,000.
A number of other hedge funds have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA grew its holdings in Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after acquiring an additional 525,214 shares during the period. State Street Corp boosted its position in shares of Agilent Technologies by 1.2% in the 3rd quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock valued at $1,903,498,000 after purchasing an additional 158,175 shares during the period. Geode Capital Management LLC boosted its position in shares of Agilent Technologies by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock valued at $1,028,241,000 after purchasing an additional 30,610 shares during the period. Van ECK Associates Corp boosted its position in shares of Agilent Technologies by 8.7% in the 4th quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock valued at $434,625,000 after purchasing an additional 258,358 shares during the period. Finally, Nordea Investment Management AB boosted its position in shares of Agilent Technologies by 2.6% in the 4th quarter. Nordea Investment Management AB now owns 3,198,715 shares of the medical research company’s stock valued at $431,603,000 after purchasing an additional 80,819 shares during the period.
Analyst Ratings Changes
A number of research firms recently weighed in on A. Citigroup increased their price target on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. JPMorgan Chase & Co. decreased their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Finally, Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $146.15.
Agilent Technologies Stock Up 0.6 %
Shares of Agilent Technologies stock opened at $127.83 on Friday. The firm has a market cap of $36.47 billion, a price-to-earnings ratio of 29.39, a P/E/G ratio of 3.64 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The stock has a 50-day simple moving average of $140.64 and a 200-day simple moving average of $139.14.
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.58% and a net margin of 19.27%. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. On average, equities research analysts expect that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.
Agilent Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is 22.76%.
Insiders Place Their Bets
In other news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More
- Five stocks we like better than Agilent Technologies
- The Risks of Owning Bonds
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- How to Use the MarketBeat Stock Screener
- 5 Best Gold ETFs for March to Curb Recession Fears
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.